COMPASS Pathways has announced it is partnering with One Mind, a leading mental health research non-profit based in California, to sponsor three “2022 One Mind – COMPASS Rising Stars Awards”.
The One Mind Rising Star Awards are given each year to promising early-career investigators who are pursuing research with the potential to dramatically advance the understanding and treatment of mental illnesses and improve patient outcomes.
Category Press Release
Published in GlobeNewswire
Companies Featured
COMPASS PathwaysCOMPASS Pathways is a publicly listed company (NASDAQ) that is developing psilocybin for treatment-resistant depression (TRD) for which it has completed a successful Phase IIb trial. COMPASS is one of the largest psychedelic companies and has received substantial investment from atai.